Using precision microbiome profiling to develop a biomarker for immune checkpoint inhibitor response and a novel therapeutic.

e21546Background: Four independent groups have demonstrated that the pre-treatment gut microbiome of cancer patients impacts the subsequent response to Immune Checkpoint Inhibitor (ICIs) therapy [1...